George Kalinsky - Alchetron, The Free Social Encyclopedia
George Kalinsky - Alchetron, The Free Social Encyclopedia
Aug 18, 2017
alchetron.com
Remembering George Kalinsky (1936-2025) | NBA.com
1:19
Remembering George Kalinsky (1936-2025) | NBA.com
10 months ago
NBA
Dr. Kalinsky on the Evolving Treatment Landscape and Sequencing ADCs in TNBC | OncLive
Dr. Kalinsky on the Evolving Treatment Landscape and Sequen…
2 months ago
onclive.com
Remembering George Kalinsky (1936-2025) - to delete
1:23
Remembering George Kalinsky (1936-2025) - to delete
10 months ago
NBA
Dr. Kalinsky Discusses the Evolution of HER2+ Breast Cancer | OncLive
Dr. Kalinsky Discusses the Evolution of HER2+ Breast Cance…
2 weeks ago
onclive.com
Dr Kalinsky on the Importance of Novel Second-Line Therapies for HR Breast Cancer | OncLive
Dr Kalinsky on the Importance of Novel Second-Line Therapies for …
1 month ago
onclive.com
Kevin Kalinsky, MD, of Winship Cancer Institute of Emory University discusses the importance of biomarker testing in guiding therapeutic decision-making in HR-positive, HER2-negative breast cancer. Watch the full video here: https://hubs.li/Q03t7GX20 | OncLive
1:06
Kevin Kalinsky, MD, of Winship Cancer Institute of Emory Universi…
123 views5 months ago
FacebookOncLive
Dr. Kalinsky on CNS Involvement in HER2 Breast Cancer | OncLive
Sep 20, 2018
onclive.com
Dr. Kalinsky on Chemotherapy for Premenopausal Patients With HR /…
Oct 13, 2022
onclive.com
Dr. Kalinsky on Initial Results of the RxPONDER Trial in HR /HER2- Bre…
Dec 9, 2020
onclive.com
Kevin Kalinsky, MD, MS, FASCO | Winship Cancer Institute of Emor…
May 18, 2024
emory.edu
Dr Kalinsky on the Importance of Biomarker Testing in HR /HER2-N…
6 months ago
onclive.com
0:29
Kevin Kalinsky, MD | Winship Cancer Institute of Emory University
726 viewsNov 13, 2020
YouTubeWinship Cancer Institute of Emory University
Dr. Kalinsky on Clinical Impact of Atezolizumab Combo in TNBC
Jan 31, 2020
onclive.com
Dr Kalinsky on Remaining Treatment Questions in Breast Ca…
Nov 17, 2023
onclive.com
Dr. Kalinsky on Updates from the TAILORx Trial in HR-Positive/HER…
May 4, 2022
onclive.com
Dr Kalinsky on the Utility of the postMONARCH Trial Regimen in H…
Jun 14, 2024
onclive.com
Dr. Kalinsky on Neratinib and Tucatinib in HER2 Metastatic Brea…
2 months ago
onclive.com
Dr Kalinsky on Unmet Needs and Findings from RxPONDER in HR /…
Aug 15, 2024
onclive.com
0:51
We are deeply saddened by the passing of the legendary photogra…
690 views10 months ago
FacebookMSG Networks
Dr. Kalinsky on Ruxolitinib Plus Trastuzumab in HER2-Positive Bre…
Jan 11, 2017
onclive.com
2:10
2024 Top Advances in Breast Cancer with Dr. Kevin Kalinsky
3 views1 month ago
YouTubeAmerican Cancer Society Journals
21:52
Breast Cancer — 5-Minute Journal Club Issue 3 with Dr Kevin Kalinsk…
67 views2 months ago
YouTubeResearch To Practice
1:30
23K views · 517 reactions | Tonight we honor The Garden's official ph…
23.9K views3 weeks ago
FacebookNew York Knicks
2:22
Kevin Kalinsky, MD, shares impressions of the RxPONDER cli…
194 viewsDec 17, 2020
YouTubeOBRoncology
1:36
Kevin Kalinsky, MD, considers the practice-changing potential of Rx…
137 viewsDec 17, 2020
YouTubeOBRoncology
Dr. Kalinksy on pCR as a Surrogate Marker for EFS in TNBC
Apr 3, 2020
onclive.com
1:45
Dr. Kalinsky on Neratinib and Tucatinib in HER2+ Metastatic Bre…
523 viewsAug 8, 2018
YouTubeOncLive
9:15
Ask the Expert: Kevin Kalinsky answers your breast cancer questi…
57 views1 month ago
YouTubeVJOncology
3:11
34K views · 411 reactions | The past is coming back to haunt Exxon. B…
34K views2 weeks ago
FacebookOil Change U.S.
See more videos
Static thumbnail place holder